SESSION II – How I treat newly diagnosed multiple myeloma
Chair: Sonja Zweegman (Amsterdam)
16:15-16:20 Introduction Sonja Zweegman (Amsterdam)
16:20-16:40 Interactive case: Karthik Ramasamy (Oxford)
Newly diagnosed transplant eligible multiple myeloma
16:40-17:00 Case-based lecture : Tandem transplant in the Dara-era? Charlotte Pawlyn (London)
17:00-17:20 Case-based lecture: Are all frail patients frail? Sonja Zweegman (Amsterdam)
17:20-17:40 Case-based lecture : Novel therapeutic approaches Alessandra Larocca (Turin)
for frail multiple myeloma patients
17:40-17:45 Brief oral communication
Daratumumab plus Lenalidomide, Bortezomib, and Peter M. Voorhees (Charlotte)
Dexamethasone in patients with transplant-eligible newly diagnosed multiple myeloma: updated
analysis of GRIFFIN after 12 months of maintenance therapy
17:45-18:15 Panel discussion
18:25-19:25 Mentored Poster Walk Martin Kortüm (Würzburg),
Charlotte Pawlyn (London)
Friday, April 16, 2021
13:30-14:30 SATELLITE SYMPOSIUM
Targeting the immune system in multiple myeloma: CAR T cell therapy and beyond
Chair: Xavier Leleu (Poitiers)
Speakers: Xavier Leleu (Poitiers), Niels van de Donk (Amsterdam), Nikhil Munshi (Boston)
This symposium is organized and sponsored by Bristol Myers Squibb
SESSION III – From risk stratification to risk-based therapy?
Chair: Hermann Einsele (Würzburg)
14:40-14:45 Introduction Hermann Einsele (Würzburg)
14:45-15:05 Interactive case: How I treat a high risk patient Faith Davies (New York)
15:05-15:25 Case-based lecture : NGS guided targeted and immune Samir Parekh (New York)
therapies in multiple myeloma
15:25-15:45 Case-based lecture : Genome-based targeted Leo Rasche (Würzburg)
immunotherapy
15:45-16:05 Case-based lecture : My DRUG - precision intervention Daniel Auclair (Boston)
in multiple myeloma
16:05-16:40 Panel discussion
16:40-16:50 Coffee break
2